Literature DB >> 9877358

Severity of respiratory syncytial virus disease related to type and genotype of virus and to cytokine values in nasopharyngeal secretions.

A Hornsleth1, B Klug, M Nir, J Johansen, K S Hansen, L S Christensen, L B Larsen.   

Abstract

BACKGROUND: Investigations concerning the severity of respiratory syncytial virus (RSV) disease as related to (1) RSV type and genotype determined respectively by PCR and restriction enzyme analysis and (2) interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) values in samples of nasopharyngeal secretion (NPS) have not been previously reported.
METHODS: We prospectively studied 105 RSV infections in the lower respiratory tract of infants and young children admitted to a pediatric department in Copenhagen during three winter seasons, 1993, 1994 and 1995. RSV strains were typed and genotyped, respectively, by PCR and nucleic acid restriction analysis and correlated to the severity of the disease. The ratio IL-6:TNF-alpha, determined from IL-6- and TNF-alpha values in samples of NPS, was related to the severity of the disease. Concentrations of IL-6 and of TNF-alpha were determined in serum samples taken during 5 weeks after the onset of illness.
RESULTS: Type B infections produced more severe disease than did type A infections, as assessed on the length of the hospital stay, use of respiratory support and the presence of an infiltrate on a chest radiograph. This difference was age-related. It was observed in infants 0 to 5 months old, but not in older age groups. Type B genotype B1122 produced more severe disease than type A genotype A2311 in infants 0 to 11 months old. Increased serum concentrations of IL-6 and TNF-alpha were detected in samples taken 1 to 2 days after the onset of illness. Whereas TNF-alpha serum concentrations remained high, IL-6 serum concentrations decreased during the following 3 to 4 weeks. The IL-6:TNF-alpha ratio in samples of NPS was related to the severity of the disease. A high ratio was related to a low severity.
CONCLUSIONS: The severity of disease in patients admitted with acute RSV infections can be correlated to the RSV type as determined by PCR, to the RSV genotype as determined by nucleic acid restriction analysis and to the ratio IL-6:TNF-alpha in NPS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9877358     DOI: 10.1097/00006454-199812000-00003

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  29 in total

Review 1.  The airway epithelium: soldier in the fight against respiratory viruses.

Authors:  Marjolaine Vareille; Elisabeth Kieninger; Michael R Edwards; Nicolas Regamey
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  Novel inflammatory markers, clinical risk factors and virus type associated with severe respiratory syncytial virus infection.

Authors:  Christy M Tabarani; Cynthia A Bonville; Manika Suryadevara; Patrick Branigan; Dongliang Wang; Danning Huang; Helene F Rosenberg; Joseph B Domachowske
Journal:  Pediatr Infect Dis J       Date:  2013-12       Impact factor: 2.129

3.  Human respiratory syncytial virus in children with acute respiratory tract infections in China.

Authors:  Rong-Fang Zhang; Yu Jin; Zhi-Ping Xie; Na Liu; Kun-Long Yan; Han-Chun Gao; Jing-Rong Song; Xin-Hui Yuan; Ni-Guang Xiao; Ming-Wei Guo; Qiong-Hua Zhou; Yun-De Hou; Zhaojun Duan
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

Review 4.  Nasal cytokines as mediators of illness during the common cold.

Authors:  William J Doyle; David P Skoner; Deborah Gentile
Journal:  Curr Allergy Asthma Rep       Date:  2005-05       Impact factor: 4.806

5.  Clinical Profiles of Respiratory Syncytial Virus Subtypes A AND B Among Children Hospitalized with Bronchiolitis.

Authors:  Federico R Laham; Jonathan M Mansbach; Pedro A Piedra; Kohei Hasegawa; Ashley F Sullivan; Janice A Espinola; Carlos A Camargo
Journal:  Pediatr Infect Dis J       Date:  2017-08       Impact factor: 2.129

6.  Seasonality, molecular epidemiology, and virulence of Respiratory Syncytial Virus (RSV): A perspective into the Brazilian Influenza Surveillance Program.

Authors:  Lucas A Vianna; Marilda M Siqueira; Lays P B Volpini; Iuri D Louro; Paola C Resende
Journal:  PLoS One       Date:  2021-05-18       Impact factor: 3.240

7.  Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model.

Authors:  Asunción Mejías; Susana Chávez-Bueno; Ana María Ríos; Jesús Saavedra-Lozano; Mónica Fonseca Aten; Jeanine Hatfield; Payal Kapur; Ana María Gómez; Hasan S Jafri; Octavio Ramilo
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

8.  Molecular and clinical characteristics of respiratory syncytial virus infections in hospitalized children.

Authors:  R Mentel; U Ilgert; U Wegner; K Zimmerman; R Bruns; L Gürtler
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

9.  Cytokine responses in primary and secondary respiratory syncytial virus infections.

Authors:  Kelechi Ugonna; Konstantinos Douros; Colin D Bingle; Mark L Everard
Journal:  Pediatr Res       Date:  2016-02-16       Impact factor: 3.756

Review 10.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.